We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+7.87%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$9.04B
AUM Growth
+$2.19B
Cap. Flow
+$1.88B
Cap. Flow %
20.78%
Top 10 Hldgs %
34.88%
Holding
3,092
New
1,032
Increased
581
Reduced
587
Closed
820

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$435M
2
AMZN icon
Amazon
AMZN
+$334M
3
MRNA icon
Moderna
MRNA
+$53.9M
4
LIN icon
Linde
LIN
+$44.2M
5
DTE icon
DTE Energy
DTE
+$43.5M

Sector Composition

Rank Sector Weight
1 Technology 15.37%
2 Consumer Discretionary 10.36%
3 Financials 7.14%
4 Industrials 6.8%
5 Healthcare 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMMR icon
1326
Immersion
IMMR
$255M
$550K 0.01%
62,693
+4,159
+7% +$35.6K
FLWS icon
1327
1-800-Flowers.com
FLWS
$240M
$547K 0.01%
17,148
-16,335
-49% -$510K
MCRI icon
1328
Monarch Casino & Resort
MCRI
$2.23B
$547K 0.01%
+8,263
New +$571K
MVIS icon
1329
Microvision
MVIS
$56.6M
$547K 0.01%
2,178
-10,918
-83% -$2.69M
CSPR
1330
DELISTED
Casper Sleep Inc.
CSPR
$547K 0.01%
66,396
+43,496
+190% +$379K
TPB icon
1331
Turning Point Brands
TPB
$1.77B
$546K 0.01%
11,934
-10,277
-46% -$475K
XNCR icon
1332
Xencor
XNCR
$2.11B
$546K 0.01%
+15,839
New +$628K
BCSF icon
1333
Bain Capital Specialty
BCSF
$772M
$545K 0.01%
35,630
+21,264
+148% +$335K
WOOF icon
1334
Petco
WOOF
$791M
$545K 0.01%
24,329
-47,296
-66% -$1.11M
OSBC icon
1335
Old Second Bancorp
OSBC
$1.28B
$543K 0.01%
+43,826
New +$587K
QMCO icon
1336
Quantum Corp
QMCO
$915M
$543K 0.01%
+3,940
New +$637K
BYND icon
1337
Beyond Meat
BYND
$245M
$541K 0.01%
+115
New +$459K
FRO icon
1338
Frontline
FRO
$9.17B
$541K 0.01%
60,062
-392,900
-87% -$3.16M
AIZ icon
1339
Assurant
AIZ
$14.2B
$540K 0.01%
+3,459
New +$540K
OPENW
1340
DELISTED
Opendoor Technologies Inc Warrants expiring 12/18/2025
OPENW
$540K 0.01%
+82,571
New +$571K
BOOT icon
1341
Boot Barn
BOOT
$4.84B
$539K 0.01%
6,411
-1,605
-20% -$118K
DADA
1342
DELISTED
Dada Nexus
DADA
$536K 0.01%
18,474
-27,539
-60% -$715K
DPZ icon
1343
Domino's
DPZ
$11.4B
$536K 0.01%
+1,150
New +$488K
QUOT
1344
DELISTED
Quotient Technology Inc
QUOT
$536K 0.01%
+49,550
New +$662K
RPT
1345
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$535K 0.01%
41,246
-4,986
-11% -$63.3K
CODX
1346
Co-Diagnostics
CODX
$7.82M
$534K 0.01%
+2,158
New +$555K
WABC icon
1347
Westamerica Bancorp
WABC
$1.34B
$534K 0.01%
9,207
+3,571
+63% +$223K
CRHC.U
1348
DELISTED
Cohn Robbins Holdings Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
CRHC.U
$533K 0.01%
52,222
-213
-0.4% -$2.19K
PSB
1349
DELISTED
PS Business Parks, Inc.
PSB
$533K 0.01%
+3,602
New +$566K
TBBK icon
1350
The Bancorp
TBBK
$2.7B
$531K 0.01%
23,092
-23,054
-50% -$541K

Similar funds

Michael Gelband's Q2 2021 Portfolio in Review

As of Q2 2021, Michael Gelband held 3,092 positions worth $9.04B, up 32% from $6.86B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Michael Gelband deployed $1.88B of net new capital in Q2 2021, opening 1,032 new positions and adding to 581 existing holdings. Its largest new stake was Linde: 151,692 shares worth $43.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $63.6M trimmed.

  • Michael Gelband's largest Q2 2021 buy was Linde: 151,692 shares worth $43.9M.
  • Michael Gelband added most to Microsoft in Q2 2021, an estimated $435M increase.
  • Michael Gelband's biggest Q2 2021 reduction was iShares Russell 1000 Value ETF, cutting an estimated $63.6M.
  • Michael Gelband fully exited Charles River Laboratories in Q2 2021, selling an estimated $27.9M.
  • Michael Gelband's ten largest holdings make up 35% of its $9.04B portfolio in Q2 2021.
  • Michael Gelband opened 1,032 new positions and closed 820 in Q2 2021.
  • Michael Gelband's portfolio value rose 32% quarter-over-quarter to $9.04B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.